This innovation developed by researchers at Wits University is a neurosponge for the restriction, repair and regeneration of damaged neuronal tissue

Traumatic spinal cord injuries, due to their devastating nature, present several interventional challenges which include: extensive inflammation...

Omega Caro-E Xtra combines Omega-3 fatty acids with 11 different carotenoids and five different forms of vitamin E, all derived from Palm oil and manufactured by a patented process in Malaysia. It also contains 50% of the daily requirement for vitamin D. The concept was created and developed in...

This invention relates to a method of producing a recombinant enzyme, more particularly, this invention relates to a method of producing water-soluble enzymatically active recombinant glycine N-acyltransferase (GLYAT (E.G. 2.1.3.13)), including the steps of providing a suitable expression host...

Central to the wellbeing of any living organism is the nucleus of the cell. It stores and organises genetic information and protects this information from other cellular components. The nucleus also communicates with the rest of the cell, exchanges proteins and RNA, and facilitates several important...

Platinum chemotherapeutics are used especially in patients with highly metastatic triple-negative breast cancers (TNBC). The chemotherapy is non-selective and toxic causing negative side effects that have been well documented. TNBC also readily acquires resistance to platinum-based therapies...

A Disintegrin and Metalloproteinase (ADAM10) is a cell-surface-expressed metalloproteinase. It is a type of protein enzyme with a catalytic mechanism involving a metal. Playing a role in various processes including cell adhesion (cells interacting and attaching to neighbouring cells), proliferation...

Triple-Negative Breast Cancer (TNBC) is a particularly aggressive cancer which mostly affects women of colour who are younger than 50 years of age. It is named for the fact that it tests negative for two hormone receptors and an excess of a certain protein; the typical indicators of breast cancer...

Avril Biopharma is a future-of-medicine company developing the tools, platforms and products to enable biotechnology innovation.  Our current business model is a Contract Development and Manufacturing Organization (CDMO) offering to develop, characterize, optimize and scale production of recombinant proteins or nanoparticles.  Our proprietary platform is comprised of Structural Genetics (TM),  AdCEV (TM)/Egg technologies, and turn-key AGRIPHARM Modular Manufacturing systems for manufacturing with our technology.

Closing date

Avril Biopharma can design and manufacture bespoke, gene-based synthetic biology products.  Our business model is focused on simplifying manufacturing for next-generation medical and veterinary products.  We are developing technologies and partnerships to make complex, custom-made, biological

The ‘OggieAir, Clear Face’ respirator provides safe, cooling airflow for users in stressful humid environments. The clear full-face visor allows the user to maintain a human connection with those around them, reducing fear, enabling lip-reading and reassuring facial expression, particularly for...